期刊文献+

西替利嗪对阿霉素所致心脏毒性的保护作用

Protective Effect of Cetririzine on Adriamycin-induced Cardiotoxicity
下载PDF
导出
摘要 目的探讨新一代抗组胺药物西替利嗪(Cetririzine,CTZ)对阿霉素(Adriamycin,ADR)所致小鼠心脏毒性的拮抗作用。方法将实验小鼠分为生理盐水对照组,生理盐水+ADR组和CTZ+ADR组,观察接受生理盐水+ADR或CTZ+ADR注射的小鼠心脏组织学变化,心肌细胞凋亡,心肌肌钙蛋白(cTnT)浓度以及小鼠的存活率。结果与生理盐水对照组比较,生理盐水+ADR组小鼠心肌细胞表现为明显的变性、空泡形成及心肌纤维断裂等,心肌细胞TUNEL阳性;CTZ可减轻ADR所致的心脏毒性并抑制ADR所诱导的心肌细胞凋亡;CTZ+ADR组的cTnT显著低于生理盐水+ADR组[(1.03±0.21)vs(8.54±0.93)ng/ml,P<0.01];CTZ+ADR组的小鼠3个月生存率明显高于生理盐水+ADR组(88%vs 64%,P<0.01)。结论CTZ可减轻ADR所致的心脏毒性并改善小鼠生存率。 Objective To investigate the protective effect of antihistamine drug cetririzine (CTZ) on adriamycin-induced cardiotoxicity. Methods Mice were injected intraperitoneally with saline+ADR, CTZ+ADR or saline alone (as control) and studied for the histology, apoptosis of the cardiocyte, cardiac troponin (cTnT) level and the overall survival. Results Heart tissues from mice receiving saline plus ADR injection had obvious degeneration, vacuolization of the myocyte, disruption of myofibrils and capillary dilation; The TUNEL staining was positive for myocytes in saline+ADR group; CTZ could alleviate all these pathological changes and inhibit ADR-induced apoptosis; Serum cTnT level was significantly lower in CTZ+ADR group (1. 03±0.21) than in saline+ADR group (8. 54±0.93 ng/ml, P〈0.01) ; The overall survival was also improved in CTZ+ADR group (88%) as compared with saline+ADR group (64%, P〈0.01). Conclusion CTZ antagonizes ADR-induced cardiotoxicity and increased survival rate.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2007年第4期459-461,共3页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 湖北省科技攻关计划资助项目(No.2005AA304B07)
关键词 阿霉素 西替利嗪 心脏毒性 adriamycin cetririzine cardiotoxicity
  • 相关文献

参考文献10

  • 1SWAINS M,WHALEY F S,EWER M S.Congestive heart failure in patients treated with doxorubicin:a retrospective analysis of tree trials[J].Cancer,2003,97(11):2869-2879.
  • 2SINGAL P K,ILISKOVIC N.Doxorubicin-induced cardiomyopathy[J].N Engl J Med,1998,339(13):900-905.
  • 3MINOTTI G,MENNA P.SALVATORELLI E,et al.Anthracyclines:molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity[J].Pharmacol Rev,2004,56(2):185-229.
  • 4PETERS J H,GORDON G R,KASHIWASE D,et al.Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin[J].Cancer Chemother Pharmacol,1981,7(1):65-69.
  • 5HORENSTEIN M S,VANDER HEIDE R S,L'ECUYER T J.Molecular basis of anthracycline-induced cardiotoxicity and it's prevention[J].Mol Genet Metab,2000,71(1/2):436-444.
  • 6GEWIRTZ D A.A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin[J].Biochem Pharmacol,1999,57(7):727-734.
  • 7DECORTI G,CANDUSSIO L,KLUGMANN F B,et al.Adriamycin-induced histamine release from heart tissue in vitro[J].Cancer Chemother Pharmacol,1991,40(4):363-372.
  • 8BARTOLI F,DECORTI G,CANDUSSIO L,et al.Effect of ketotifen on adriamycin toxicity:role of histamine[J].Cancer Letter,1988,39(1):145-152.
  • 9ZHANG Y,BERGER S A.Ketotifen reverses MDR1-mediated multidrug resistance in human breast cancer cells in vitro and alleviates cardio toxicity induced by doxorubicin in vivo[J].Cancer Chemother Pharmacol,2003,51(5):407-414.
  • 10GOMMERMAN J L,BERGER S A.Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx[J].Blood,1998,91(6):1891-1896.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部